The mechanism of gait disorder in patients with cerebral small vessel disease (CSVD) remains unclear. Limited studies have compared the effect of cerebral microbleeds (CMBs) and lacunes on gait disturbance in CSVD patients in different anatomical locations.
Objective:
To investigate the relationship of quantitative gait parameters with varied anatomically located MRI imaging markers in patients with CSVD.
Methods:
Quantitative gait tests were performed on 127 symptomatic CSVD patients all with diffuse distributed white matter hyperintensities (WMHs). CMBs and lacunes in regard to anatomical locations and burdens were measured. The correlation between CSVD imaging markers and gait parameters was evaluated using general linear model analysis.
Results:
Presence of CMBs was significantly associated with stride length (β= –0.098, p = 0.0272) and right step length (β= –0.054, p = 0.0206). Presence of CMBs in basal ganglia (BG) was significantly associated with stride length and step length. Presence of CMBs in brainstem was significantly associated with gait parameters including stride length, step length, step height, and step width. Presence of lacunes in brainstem was significantly associated with gait speed (β= –0.197, p = 0.0365). However, presence of lacunes in the other areas was not associated with worse gait performances.
Conclusion:
BG and brain stem located CMBs contributed to gait impairment in symptomatic CSVD patients.
VeroneseN, StubbsB, VolpatoS, ZulianiG, MaggiS, CesariM, LipnickiDM, SmithL, SchofieldP, FirthJ, VancampfortD, KoyanagiA, PilottoA, CeredaE (2018) Association between gait speed with mortality, cardiovascular disease and cancer: A systematic review and meta-analysis of prospective cohort studies. J Am Med Dir Assoc19, 981–988.e7.
3.
PereraS, PatelKV, RosanoC, RubinSM, SatterfieldS, HarrisT, EnsrudK, OrwollE, LeeCG, ChandlerJM, NewmanAB, CauleyJA, GuralnikJM, FerrucciL, StudenskiSA (2016) Gait speed predicts incident disability: A pooled analysis. J Gerontol A Biol Sci Med Sci71, 63–71.
van der HolstHM, TuladharAM, ZerbiV, van UdenIWM, de LaatKF, van LeijsenEMC, GhafoorianM, PlatelB, BergkampMI, van NordenAGW, NorrisDG, van DijkEJ, KiliaanAJ, de LeeuwFE (2018) White matter changes and gait decline in cerebral small vessel disease. Neuroimage Clin17, 731–738.
6.
MurrayME, SenjemML, PetersenRC, HollmanJH, PreboskeGM, WeigandSD, KnopmanDS, FermanTJ, DicksonDW, JackCRJr (2010) Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Arch Neurol67, 1379–1385.
KimYJ, KwonHK, LeeJM, ChoH, KimHJ, ParkHK, JungNY, San LeeJ, LeeJ, JangYK, KimST, LeeKH, ChoeYS, KimYJ, NaDL, SeoSW (2016) Gray and white matter changes linking cerebral small vessel disease to gait disturbances. Neurology86, 1199–1207.
9.
PinterD, RitchieSJ, DoubalF, GattringerT, MorrisZ, BastinME, Del C Valdés HernándezM, RoyleNA, CorleyJ, MuñozManiegaS, PattieA, DickieDA, StaalsJ, GowAJ, StarrJM, DearyIJ, EnzingerC, FazekasF, WardlawJ (2017) Impact of small vessel disease in the brain on gait and balance. Sci Rep7, 41637.
10.
de LaatKF, van den BergHAC, van NordenAGW, GonsRAR, Olde RikkertMGM, de LeeuwFE (2011) Microbleeds are independently related to gait disturbances in elderly individuals with cerebral small vessel disease. Stroke42, 494–497.
11.
LiP, WangY, JiangY, ZhangK, YangQ, YuanZ, ZhuZ, TangW, FanM, YeW, DongQ, JinL, DingD, CuiM, ChenX (2020) Cerebral small vessel disease is associated with gait disturbance among community-dwelling elderly individuals: The Taizhou imaging study. Aging (Albany NY)12, 2814–2824.
FisherM, FrenchS, JiP, KimRC (2010) Cerebral microbleeds in the elderly. Stroke41, 2782–2785.
14.
CaplanLR (2015) Lacunar infarction and small vessel disease: Pathology and pathophysiology. J Stroke17, 2–6.
15.
ZhangZ, HongX, LiH (1999) The mini-mental state examination in the Chinese residents population aged 55 years and over in the urban and rural areas of Beijing. Chin J Neurol32, 149–153.
16.
WenHB, ZhangZX, NiuFS, LiL (2008) [The application of Montreal cognitive assessment in urban Chinese residents of Beijing.]. Zhonghua Nei Ke Za Zhi47, 36–39.
17.
WardlawJM, SmithEE, BiesselsGJ, CordonnierC, FazekasF, FrayneR, LindleyRI, O’BrienJT, BarkhofF, BenaventeOR, BlackSE, BrayneC, BretelerM, ChabriatH, DecarliC, de LeeuwFE, DoubalF, DueringM, FoxNC, GreenbergS, HachinskiV, KilimannI, MokV, OostenbruggeRV, PantoniL, SpeckO, StephanBC, TeipelS, ViswanathanA, WerringD, ChenC, SmithC, van BuchemM, NorrvingB, GorelickPB, DichgansM; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1)
(2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol12, 822–838.
18.
FazekasF, ChawlukJ, AlaviA, HurtigH, ZimmermanR (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol149, 351–356.
19.
PasquierF, LeysD, WeertsJGE, Mounier-VehierF, BarkhofF, ScheltensP (1996) Inter-and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol36, 268–272.
20.
JanawayBM, SimpsonJE, HoggardN, HighleyJR, ForsterG, DrewD, GebrilOH, MatthewsFE, BrayneC, WhartonSB, IncePG; MRC Cognitive Function and Ageing Neuropathology Study
(2014) Brain haemosiderin in older people: Pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds. Neuropathol Appl Neurobiol40, 258–269.
21.
SchipperHM (2004) Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev3, 265–301.
22.
LiY, HeY, GuanQ, LiuW, HanH, NieZ (2012) Disrupted iron metabolism and ensuing oxidative stress may mediate cognitive dysfunction induced by chronic cerebral hypoperfusion. Biol Trace Elem Res150, 242–248.
23.
SchragM, CroftonA, ZabelM, JiffryA, KirschD, DicksonA, MaoXW, VintersHV, DomailleDW, ChangCJ, KirschW (2011) Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer’s disease. J Alzheimers Dis24, 137–149.
24.
ChiuWT, ChanL, WuD, KoTH, ChenDY, HongCT (2018) Cerebral microbleeds are associated with postural instability and gait disturbance subtype in people with Parkinson’s disease. Eur Neurol80, 335–340.
25.
ChenH, ZhangM, LiuG, WangX, WangZ, MaH, PanY, WangD, WangY, FengT (2020) Effect of small vessel disease burden and lacunes on gait/posture impairment in Parkinson’s disease. Neurol Sci41, 3617–3624.
26.
YangS, LiX, QinW, YangL, HuW (2022) Association between large numbers of enlarged perivascular spaces in basal ganglia and motor performance in elderly individuals: A cross-sectional study. Clin Interv Aging17, 903–913.
27.
NielsenJB, CroneC, HultbornH (2007) The spinal pathophysiology of spasticity – from a basic science point of view. Acta Physiol (Oxf)189, 171–180.
28.
TakakusakiK (2017) Functional neuroanatomy for posture and gait control. J Mov Disord10, 1–17.
29.
LiS, FranciscoGE, ZhouP (2018) Post-stroke hemiplegic gait: New perspective and insights. Front Physiol9, 1021.
30.
ZhaoW, YouH, JiangS, ZhangH, YangY, ZhangM (2019) Effect of Pro-kin visual feedback balance training system on gait stability in patients with cerebral small vessel disease. Medicine (Baltimore)98, e14503.
31.
WilsonJ, AllcockL, Mc ArdleR, TaylorJP, RochesterL (2019) The neural correlates of discrete gait characteristics in ageing: A structured review. Neurosci Biobehav Rev100, 344–369.
32.
WeiP, ZouT, LvZ, FanY (2020) Functional MRI reveals locomotion-control neural circuits in human brainstem. Brain Sci10, 757.
33.
de LaatKF, van NordenAG, GonsRA, van OudheusdenLJ, van UdenIW, BloemBR, ZwiersMP, de LeeuwFE (2010) Gait in elderly with cerebral small vessel disease. Stroke41, 1652–1658.
34.
SmithEE, O’DonnellM, DagenaisG, LearSA, WielgoszA, SharmaM, PoirierP, StottsG, BlackSE, StrotherS, NoseworthyMD, BenaventeO, ModiJ, GoyalM, BatoolS, SanchezK, HillV, McCrearyCR, FrayneR, IslamS, DeJesusJ, RangarajanS, TeoK, YusufS; PURE Investigators
(2015) Early cerebral small vessel disease and brain volume, cognition, and gait. Ann Neurol77, 251–261.
35.
WangN, AllaliG, KesavadasC, NooneML, PradeepVG, BlumenHM, VergheseJ (2016) Cerebral small vessel disease and motoric cognitive risk syndrome: Results from the Kerala-Einstein Study. J Alzheimers Dis50, 699–707.
36.
ChoiP, RenM, PhanTG, CallisayaM, LyJV, BeareR, ChongW, SrikanthV (2012) Silent infarcts and cerebral microbleeds modify the associations of white matter lesions with gait and postural stability. Stroke43, 1505–1510.
PoelsMMF, VernooijMW, IkramMA, HofmanA, KrestinGP, van der LugtA, BretelerMMB (2010) Prevalence and risk factors of cerebral microbleeds. Stroke41, S103–S106.
39.
HilalS, MokV, YounYC, WongA, IkramMK, ChenCL-H (2017) Prevalence, risk factors and consequences of cerebral small vessel diseases: Data from three Asian countries. J Neurol Neurosurg Psychiatry88, 669–674.
